MAZZANTI, BENEDETTA
MAZZANTI, BENEDETTA
Medicina Sperimentale e Clinica
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients.
1998 A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells
2019 Irdani, Tiziana; Mazzanti, Benedetta; Ballerini, Lara; Saccardi, Riccardo; Torre, Renato
A proteomic approach to characterize a native antigen involved in autoantibody response in Multiple Sclerosis by a structure-based designed glycopeptide.
2004 B. Mazzanti; M. Pazzagli; M.C. Alcaro; B. Mulinacci; E. Peroni; F. Nuti; G. Sabatino; M.C. Pozo-Carrero; A. Carotenuto; B. Bonetti; L. Battistini; D. Franciotta; S. Sotgiu; R. Lanzillo; M. Chelli; P. Rovero; F. Lolli; A. M. Papini
A unique neuroendocrine cell model derived from the human foetal neural crest.
2020 Rapizzi E, Benvenuti S, Deledda C, Martinelli S, Sarchielli E, Fibbi B, Luciani P, Mazzanti B, Pantaleo M, Marroncini G, Vannelli GB, Maggi M, Mannelli M, Luconi M, Peri A.
An innovative approach to the synthesis of N-glycopeptides
2004 E. Peroni; F. Peri; F. Nuti; B. Mazzanti; M. Chelli; A.M. Papini
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
2005 F. LOLLI; MULINACCI B; CAROTENUTO A; BONETTI B; SABATINO G; MAZZANTI B; D'URSI AM; NOVELLINO E; PAZZAGLI M; LOVATO L; ALCARO MC; PERONI E; POZO-CARRERO MC; NUTI F; BATTISTINI L; BORSELLINO G; CHELLI M; ROVERO P; PAPINI AM.
Asparaginyl glucose is fundamental for autoantibody recognition in Multiple Sclerosis.
2005 F.Nuti; I. Paolini; B.Mazzanti; F. Real-Fernàndez; M.C. Pozo-Carrero; M. Chelli; P.Rovero; A.M. Papini
Beta-hairpin glycopeptides as mimetic autoantigens in Multiple Sclerosis
2004 B. Mulinacci; I. Paolini; A. Carotenuto; B. Mazzanti; M. Pazzagli; M. Chelli; F. Lolli; P. Rovero; A.M. Papini
Beta-Hairpin glycopeptides as mimetic autoantigens in multiple sclerosis
2005 B. Mulinacci; I. Paolini; A. Carotenuto; B. Mazzanti; M. Pazzagli; M. Chelli; F. Lolli; P. Rovero; A.M. Papini
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/Regeneration. Preclinical Aspects
2013 Formigli, L.; Paternostro, F.; Tani, A; Mirabellla, C.; Quattrini Li, A.; Nosi, D.; Saccardi, R.; Mazzanti, B.; Lo Russo, G.; Zecchi, S.
Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation in vitro: therapeutic potential for muscle repair/regeneration.
2012 C. Sassoli; F. Chellini; A. Pini; B. Mazzanti; S. Nistri; S. Zecchi; L. Formigli.
Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF.
2012 C. Sassoli; A. Pini ;F. Chellini ; B. Mazzanti; S. Nistri; D. Nosi; R. Saccardi; F. Quercioli;S. Zecchi;F. Formigli
CD133+ cells in culture with rosiglitazone differentiate in fully differentiated Langerhans cells
2012 Maria Ida Bonetti; Michela Santosuosso; Benedetta Mazzanti; Serena Urbani; Alessandra Aldinucci; Clara Ballerini; Riccardo Saccardi; Alberto Bosi; Paolo Romagnoli
Combinatorial approach to develop the optimal glycopeptide as molecular probe to characterize autoantibodies in Multiple Sclerosis.
2005 E. Peroni; M.C. Alcaro; F Barbetti; F. Nuti; F. Real-Fernàndez; B. Mazzanti; M.Chelli; P. Rovero; A.M. Papini.
Cross-reactivity studies of rMOG(ED) with synthetic putative autoantigens CSF114(Glc) and [N-31(Glc)]hMOG(30-50) in multiple sclerosis patients' sera.
2005 B. Mulinacci; C. Breithaupt; P.P. Pal; N. Budisa; M. Pazzagli; B. Mazzanti; P. Rovero; L. Moroder; A.M. Papini.
CROSS-REACTIVITY STUDIES OF RMOGED WITH SYNTHETIC PUTATIVE AUTOANTIGENS CSF114(GLC) AND [N31(GLC)]HMOG(30-50)IN MULTIPLE SCLEROSIS PATIENTS'SERA
2006 B. MULINACCI; M. PAZZAGLI; B. MAZZANTI; P. ROVERO; L. MORODER; A. PAPINI; C. BREITHAUPT; P. PRAJNA; B. NEDIJLKO
Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells.
2000 MAZZANTI B.; HEMMER B.; TRAGGIAI E.; BALLERINI C.; MCFARLAND H.F.; MASSACESI L.; MARTIN R.; VERGELLI M.;
Defining the role of mesenchymal stromal cells on the regulation of matrix metalloproteinases in skeletal muscle cells.
2014 Chiara, Sassoli; Daniele, Nosi; Alessia, Tani; Flaminia, Chellini; Benedetta, Mazzanti; Franco, Quercioli; Sandra, Zecchi; Lucia, Formigli
Dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet-rich plasma as a potential tool for tissue repair and regeneration.
2012 L. Formigli; S. Benvenuti; R. Mercatelli; F. Quercioli; A. Tani; C. Mirabella; A. Dama; R. Saccardi; B. Mazzanti; I. Cellai; S. Zecchi-Orlandini
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA
2014 Di Franco A; Guasti D; Mazzanti B; Ercolino T; Francalanci M; Nesi G; Bani D; Forti G; Mannelli M; Valeri A; Luconi M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients. | 1998 | A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI | |
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells | 2019 | Irdani, Tiziana; Mazzanti, Benedetta; Ballerini, Lara; Saccardi, Riccardo; Torre, Renato | |
A proteomic approach to characterize a native antigen involved in autoantibody response in Multiple Sclerosis by a structure-based designed glycopeptide. | 2004 | B. Mazzanti; M. Pazzagli; M.C. Alcaro; B. Mulinacci; E. Peroni; F. Nuti; G. Sabatino; M.C. Pozo-Carrero; A. Carotenuto; B. Bonetti; L. Battistini; D. Franciotta; S. Sotgiu; R. Lanzillo; M. Chelli; P. Rovero; F. Lolli; A. M. Papini | |
A unique neuroendocrine cell model derived from the human foetal neural crest. | 2020 | Rapizzi E, Benvenuti S, Deledda C, Martinelli S, Sarchielli E, Fibbi B, Luciani P, Mazzanti B, Pantaleo M, Marroncini G, Vannelli GB, Maggi M, Mannelli M, Luconi M, Peri A. | |
An innovative approach to the synthesis of N-glycopeptides | 2004 | E. Peroni; F. Peri; F. Nuti; B. Mazzanti; M. Chelli; A.M. Papini | |
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. | 2005 | F. LOLLI; MULINACCI B; CAROTENUTO A; BONETTI B; SABATINO G; MAZZANTI B; D'URSI AM; NOVELLINO E; PAZZAGLI M; LOVATO L; ALCARO MC; PERONI E; POZO-CARRERO MC; NUTI F; BATTISTINI L; BORSELLINO G; CHELLI M; ROVERO P; PAPINI AM. | |
Asparaginyl glucose is fundamental for autoantibody recognition in Multiple Sclerosis. | 2005 | F.Nuti; I. Paolini; B.Mazzanti; F. Real-Fernàndez; M.C. Pozo-Carrero; M. Chelli; P.Rovero; A.M. Papini | |
Beta-hairpin glycopeptides as mimetic autoantigens in Multiple Sclerosis | 2004 | B. Mulinacci; I. Paolini; A. Carotenuto; B. Mazzanti; M. Pazzagli; M. Chelli; F. Lolli; P. Rovero; A.M. Papini | |
Beta-Hairpin glycopeptides as mimetic autoantigens in multiple sclerosis | 2005 | B. Mulinacci; I. Paolini; A. Carotenuto; B. Mazzanti; M. Pazzagli; M. Chelli; F. Lolli; P. Rovero; A.M. Papini | |
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/Regeneration. Preclinical Aspects | 2013 | Formigli, L.; Paternostro, F.; Tani, A; Mirabellla, C.; Quattrini Li, A.; Nosi, D.; Saccardi, R.; Mazzanti, B.; Lo Russo, G.; Zecchi, S. | |
Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation in vitro: therapeutic potential for muscle repair/regeneration. | 2012 | C. Sassoli; F. Chellini; A. Pini; B. Mazzanti; S. Nistri; S. Zecchi; L. Formigli. | |
Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. | 2012 | C. Sassoli; A. Pini ;F. Chellini ; B. Mazzanti; S. Nistri; D. Nosi; R. Saccardi; F. Quercioli;S. Zecchi;F. Formigli | |
CD133+ cells in culture with rosiglitazone differentiate in fully differentiated Langerhans cells | 2012 | Maria Ida Bonetti; Michela Santosuosso; Benedetta Mazzanti; Serena Urbani; Alessandra Aldinucci; Clara Ballerini; Riccardo Saccardi; Alberto Bosi; Paolo Romagnoli | |
Combinatorial approach to develop the optimal glycopeptide as molecular probe to characterize autoantibodies in Multiple Sclerosis. | 2005 | E. Peroni; M.C. Alcaro; F Barbetti; F. Nuti; F. Real-Fernàndez; B. Mazzanti; M.Chelli; P. Rovero; A.M. Papini. | |
Cross-reactivity studies of rMOG(ED) with synthetic putative autoantigens CSF114(Glc) and [N-31(Glc)]hMOG(30-50) in multiple sclerosis patients' sera. | 2005 | B. Mulinacci; C. Breithaupt; P.P. Pal; N. Budisa; M. Pazzagli; B. Mazzanti; P. Rovero; L. Moroder; A.M. Papini. | |
CROSS-REACTIVITY STUDIES OF RMOGED WITH SYNTHETIC PUTATIVE AUTOANTIGENS CSF114(GLC) AND [N31(GLC)]HMOG(30-50)IN MULTIPLE SCLEROSIS PATIENTS'SERA | 2006 | B. MULINACCI; M. PAZZAGLI; B. MAZZANTI; P. ROVERO; L. MORODER; A. PAPINI; C. BREITHAUPT; P. PRAJNA; B. NEDIJLKO | |
Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells. | 2000 | MAZZANTI B.; HEMMER B.; TRAGGIAI E.; BALLERINI C.; MCFARLAND H.F.; MASSACESI L.; MARTIN R.; VERGELLI M.; | |
Defining the role of mesenchymal stromal cells on the regulation of matrix metalloproteinases in skeletal muscle cells. | 2014 | Chiara, Sassoli; Daniele, Nosi; Alessia, Tani; Flaminia, Chellini; Benedetta, Mazzanti; Franco, Quercioli; Sandra, Zecchi; Lucia, Formigli | |
Dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet-rich plasma as a potential tool for tissue repair and regeneration. | 2012 | L. Formigli; S. Benvenuti; R. Mercatelli; F. Quercioli; A. Tani; C. Mirabella; A. Dama; R. Saccardi; B. Mazzanti; I. Cellai; S. Zecchi-Orlandini | |
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA | 2014 | Di Franco A; Guasti D; Mazzanti B; Ercolino T; Francalanci M; Nesi G; Bani D; Forti G; Mannelli M; Valeri A; Luconi M |